The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation

Cell Death & Differentiation, Published online: 16 October 2023; doi:10.1038/s41418-023-01232-yThe BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation

https://www.nature.com/articles/s41418-023-01232-y

Source: Cell Death and Differentiation - October 16, 2023 Category: Cytology Authors: Peng Liu Liwei Zhao Laurence Zitvogel Oliver Kepp Guido Kroemer Source Type: research

More News: Cytology